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Abstract
Background: The significant advances in microarray and proteomics analyses have resulted in an exponential increase
in potential new targets and have promised to shed light on the identification of disease markers and cellular pathways.
We aim to collect and decipher the HCC-related genes at the systems level.
Results: Here, we build an integrative platform, the Encyclopedia of Hepatocellular Carcinoma genes Online, dubbed
EHCO http://ehco.iis.sinica.edu.tw, to systematically collect, organize and compare the pileup of unsorted HCC-related
studies by using natural language processing and softbots. Among the eight gene set collections, ranging across PubMed,
SAGE, microarray, and proteomics data, there are 2,906 genes in total; however, more than 77% genes are only included
once, suggesting that tremendous efforts need to be exerted to characterize the relationship between HCC and these
genes. Of these HCC inventories, protein binding represents the largest proportion (~25%) from Gene Ontology
analysis. In fact, many differentially expressed gene sets in EHCO could form interaction networks (e.g. HBV-associated
HCC network) by using available human protein-protein interaction datasets. To further highlight the potential new
targets in the inferred network from EHCO, we combine comparative genomics and interactomics approaches to analyze
120 evolutionary conserved and overexpressed genes in HCC. 47 out of 120 queries can form a highly interactive
network with 18 queries serving as hubs.
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Conclusion:  This architectural map may represent the first step toward the attempt to decipher the
hepatocarcinogenesis at the systems level. Targeting hubs and/or disruption of the network formation might reveal novel
strategy for HCC treatment.
Background
Hepatocellular carcinoma (HCC) is the most common
liver malignancy and is one of the leading causes of death
worldwide. Its incidence has been especially prevalent
among Asian populations. Due to HCC being the top
cause of cancer death worldwide, research on its cause,
diagnosis, and treatment continues into the post-genomic
era. However, the carcinogenesis of HCC still remains
poorly understood.
In the post-genomic era, advances in tools and technolo-
gies have provided an excellent opportunity to better
understand the complex interaction of hepatocarcinogen-
esis. For example, genome-wide microarray technologies,
which are widely used to monitor global gene expression
in cancer [1-14], have identified numerous differentially
expressed genes and enable cancer research to succeed
where traditional methods have faltered. These high-
throughput analyses have revolutionized the way that
HCC is diagnosed and classified. It is generally believed
that microarrays are well able to shed light on the identi-
fication of disease markers for diagnosis and potential tar-
gets for treatment. However, there are several bottlenecks
associated with moving from microarray profiling to tar-
get identifications. The challenges include: (1) infrastruc-
tural challenges, such as the creation of data models and
databases for storing data, the integration of data with
external databases and the extraction of information from
natural language text; (2) information overload, where
there are many HCC-related microarray studies [1-14], the
gene annotations are scattered across different databases
and the content is difficult to update or improve. Moreo-
ver, an exponential growth in both the number and the
size of specialized biological databases has also made the
task of performing cross-site browsing or iterative query-
ing very tedious and challenging. There have been several
attempts, such as GeneWebEx [39] and GENA [40] to inte-
grate cross-site information, but these often lack adequate
annotation related to HCC. All this calls for the establish-
ment of an infrastructure that can collect such scattered
annotations, present them in a user-friendly way, and
allow viewers to participate actively in its making.
To embrace the paradigm shift to the next generation of
the web and to provide web-based services, we have
designed an information harvesting infrastructure, Ency-
clopedia of Hepatocellular Carcinoma genes Online,
dubbed EHCO, which employs softbots (or Web wrapper
agents [15]) to collect scattered gene annotations either by
mining data sources directly or by querying publicly acces-
sible databases. To overcome the obstacles that EHCO
reports merely descriptive results from various studies, we
notice that protein bindings from Gene Ontology analysis
represent the largest proportion (~25%) in the molecular
function category. By using available protein-protein
interaction datasets, a highly interactive biological net-
work and novel hubs can be revealed among these seem-
ingly random HCC inventories.
Results and Discussion
The architecture of EHCO
EHCO adapts the PLONE platform, an open source con-
tent management system (CMS) with a workflow engine,
pre-configured security and a set of content types, to create
an infrastructure to support flexible storage and presenta-
tion (Figure 1A). The advantage of using PLONE is that
PLONE supports Wiki so that EHCO can be extended
beyond the context of HCC research. One example is Liver
Fibrosis [41], a sister site of EHCO, which provides liver
necroinflammatory and fibrosis-related gene knowledge
[38]. Both sites shared the same server, same PLONE, the
same mySQL database, and most of the python codes. The
uniqueness of EHCO lies in its ability to allow registered
users to contribute their own work to EHCO to create an
integrated biological information portal for efficient
information sharing and extensive aggregation of
research-related topics. To achieve the uniqueness, EHCO
uses ZWiki as its content management and presentation
platform. ZWiki is one of many open-source Wiki plat-
forms freely available online. With ZWiki, users can col-
laboratively create their new Web pages to enrich the
contents of EHCO.
The differentially expressed gene set collections in EHCO
A fundamental part of EHCO is the collection of eight
gene sets related to HCC either from PubMed or diverse
high-throughput studies (Figure 2A). Since different labs
obtained all gene sets independently at different time,
they used a wide variety of gene IDs and appeared in many
cases with different gene names, resulting in difficulty in
gene ID comparisons. Therefore, we established Gene
Name Service [49], a comprehensive gene name cross-ref-
erence database, to unify all of the aliases automatically.
Since the amount of biomedical literatures available on
the web is rapidly increasing, manual information extrac-
tion from search results is usually unable to identify arti-
cles of interest immediately. Therefore, in the PubMed
section, we had extracted 1,084 genes (with HUGO-BMC Bioinformatics 2007, 8:66 http://www.biomedcentral.com/1471-2105/8/66
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approved gene names) from approximately 4,500
abstracts in the PubMed category (Figure 1B) (detail in
Methods section). For those genes that either do not have
HUGO-approved gene names or fail to be included from
PubMed search, they were placed under TableX when
reading the articles. Among the HCC-related microarray
studies, EHCO was further reorganized into five gene sets.
Differentially expressed HCC-related gene sets were col-
lected from four major studies, including Chen et al., [1]
(referred to as SMD1648), Neo et al., [2] (referred to as
GIS), Lee et al., [3] (referred to as Lee_NIH), and Kim et
al., [4] (referred to as Kim_NIH), and ten additional
reports [5-14], which were manually keyed in and are
referred to as TableX_mRNA. The differentially expressed
genes collected from these sets ranged from 199 (GIS) to
1,161 (SMD1648). Similarly, eight proteomics reports
[16-23], which represented relatively small collections of
104 proteins, were also manually keyed in and are referred
to as TableX_protein. In addition, the SAGE dataset [48]
was collected from CGAP library by using a 2-fold differ-
ence in tumor vs. non-tumor sample as criteria, resulting
in a gene set of 391 genes.
Intersection genes
Among the eight gene set collections, there are 2906 non-
redundant genes in total. Figure 2A shows the intersection
between each gene set. The biggest intersection, which
contained 138 genes, appeared between SMD1648 and
PubMed. Interestingly, 68.0% SMD1648 (790 out of
1,161) and 69.6% PubMed (754 out of 1,084) collections
(referred to as distinct genes in Figure 2A) had not been
reported in other gene sets. Similarly, a comparison was
made that revealed 77% genes were only counted once
among each gene set (Figure 2B), suggesting that tremen-
dous efforts will be needed to characterize the relation-
ship between HCC and these genes generated from
diverse measurements. A cross-dataset comparison of
SAGE and five microarray datasets (mRNA-based meas-
urements) revealed the top 23 intersection genes, which
appeared at least 4 times in EHCO, among each gene set.
The architecture of EHCO Figure 1
The architecture of EHCO. (A) EHCO uses a Content Management System, PLONE, to maintain different types of infor-
mation. PLONE supports workflow design, content sharing, front-end editing, and member registration. Softbots, which inter-
act with a software environment by using and interpreting the environment feedback, are used as annotation collectors to 
retrieve scattered genomic information across the Internet. EHCO also implements Natural Language Processing, a subfield of 
artificial intelligence and linguistics, and Gene Name Service, a comprehensive cross reference service of all widely used gene 
ID nomenclatures, to support the annotation engine, which is supported by mySQL database and python-written scripts. The 
Presentation Engine uses Wiki pages to allow dynamic information display as well as user commenting. (B) We performed bio-
logical information retrieval (IR) to obtain PubMed abstracts that may contain gene-HCC relationships, followed by two infor-
mation extraction tasks: (1) Named Entity Recognition (NER): to recognize biomedical named entities (NEs) and (2) Named 
Entity Relation Recognition (NERR), as shown in the flowchart.
(A)
(B)BMC Bioinformatics 2007, 8:66 http://www.biomedcentral.com/1471-2105/8/66
Page 4 of 12
(page number not for citation purposes)
Statistics analysis of EHCO collections Figure 2
Statistics analysis of EHCO collections. (A) Gene intersections among the 8 different gene sets collected in EHCO. The 
numbers in the parenthesis are the gene numbers in each dataset. The intersection between each dataset is shown in the box, 
e.g. SMD1648 has 138 genes in common with PubMed. (B) Distribution of HCC-related genes in EHCO. (C, D) Top 5 path-
ways, as analyzed by KEGG and BioCarta pathway collectors, associated with HCC-related genes in EHCO. (E) Chromosomal 
distribution of HCC-related genes in EHCO.
(A)
(B)
(C)
(D)
(E)BMC Bioinformatics 2007, 8:66 http://www.biomedcentral.com/1471-2105/8/66
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19 out of the 23 genes shared consistent gene expression
patterns (tumor vs. normal; up- or down-regulated)
(shown as Up & Down) (Table 1). In contrast, 4 genes had
discrepancies in HCC expression patterns (bold in Table
1). This might be the result of changes in gene expression
associated with different pathophysiological states, the
type of sample collected, etc. Fortunately, three out of four
had PubMed records, including FABP1 (overexpression in
HCC [24]), IGFBP3 (down-regulation in HCC [25]), and
SGK (overexpression in HCC [10]). Since we did not have
an unbiased method to distinguish the accuracy of
NNMT, Q-RT-PCR was applied to evaluate the expression
patterns by using 21 pairwised HCC patient specimens.
The down-regulation profiles were observed in 19 out of
21 paired samples analyzed (Figure 3A). In addition to
NNMT, we chose PEG10 [26,27], which also had contra-
dictory expression patterns in our collections, and per-
formed Q-RT-PCR to validate the gene expression
signatures. Figure 3B showed that overexpression of
PEG10 was observed in 17 out of 21 HCC patient sam-
ples. Altogether, the majority of EHCO collections
(~77%) appeared only once and there were some discrep-
ancies among gene sets, indicative of a need for an imme-
diate further validation of these different measurements
by using different HCC samples. Therefore, we especially
welcome other investigators to contribute their validation
data to our EHCO data warehouse.
Pathway and chromosome assignments
Pathway information is important for an understanding
of the functionality of genes and proteins. EHCO inte-
grated two well-known pathway databases, KEGG [28]
and BioCarta [51]. Figure 2C and 2D show the top five
KEGG and BioCarta pathways that have the most HCC-
related genes associated with them in these two public
accessible pathway collections. Out of EHCO's current
collections, 2385 genes were identified as part of the asso-
ciated pathways from KEGG. The most associated path-
way is cytokine-cytokine receptor interaction, which has
102 genes associated with it. The most associated pathway
in BioCarta is the MAPK signaling pathway, which has 38
genes associated with it. Interestingly, these two public
accessible pathway analyzers did not have a similar data-
set for their top 5 collections except for the MAPK signal-
ing pathway. This is probably due to the fact that the
primary areas of KEGG collections are metabolic path-
ways whereas the coverage areas of BioCarta are signaling
pathways. Moreover, analysis of chromosome distribu-
tion indicates that the largest proportion belongs to chro-
mosome 1 (343 genes), whereas Y chromosome contains
the least genes, namely only 2 EHCO genes (Figure 2E).
Harvesting gene annotations through softbots and 
weblinks
The disease specific gene/protein expression pattern can
provide important clues about gene function. Currently,
~1000 genes-related to HCC are in our PubMed collec-
tions (or referred to as small scale studies). To date, EHCO
has extended the HCC-related gene collections to 2,906
genes. The study of these genes can be accelerated by func-
tional annotations.
To organize diverse HCC-related datasets, the annotation
handler stepped in to annotate the EHCO collected gene
sets. We use Softbots [29] to harvest gene annotations
from various web resources. A softbot is an intelligent
software robot that acts, on behalf of the user, to achieve
certain goals. Given the resources, which can be online
websites, databases, or documents, a softbot extracts the
information that it has been targeted to. Since softbot can
be fragile against changes to the online resources, we used
a Java program, called Agent Toolbox [15] to create and
maintain these softbots. Agent Toolbox 'learns' the infor-
mation extraction rules from users' labels on the web page
with a machine-learning algorithm [36,37]. As a result, we
can efficiently repair and maintain our softbots. In this
study, individual softbots were used to mine different tar-
gets. These programs will periodically update the latest
information from NCBI databases and download them
into EHCO. Finally, we created a presentation engine inte-
grating all the information into a single user-friendly page
view as "Gene Info" (Figure 1A). As a result, each gene
annotation webpage displays the most up-to-date infor-
mation from various databases, e.g. EBI [52], and SMART
[30].
To rapidly interrogate the expression patterns of our col-
lection, two gene sets (SMD1648 and PubMed) were used
as templates to annotate our EHCO collections. Firstly,
SMD-HCC dataset reports not only those differentially
expressed gene in SMD1648, but also records the expres-
sion patterns of other genes (~16,000 genes), which are
not statistically significant in the original data analysis.
Inclusion of this on-line quantitative evaluation of gene
expression provides a rapid visualization of global trends
in gene expression. Secondly, we applied a natural lan-
guage processing technique to extract information from
the abstracts, followed by a summary table illustrating the
gene and disease relationship. Toward this goal, we have
developed a tool, as described in the Method section, to
annotate genes, diseases, and other HCC-related informa-
tion (i.e. HBV, HCV) from PubMed abstracts to provide a
brief summary of each EHCO genes.
Detection of inferred biological network of HCC
The availability of HCC-related gene catalogs now enables
elucidation of molecular mechanisms governing hepato-BMC Bioinformatics 2007, 8:66 http://www.biomedcentral.com/1471-2105/8/66
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carcinogenesis at the systems level. However, these gene
catalogs give no direct clues, at least not immediately evi-
dent from the gene symbols, to the underlying carcino-
genesis processes. Gene Ontology (GO) analysis [42],
which allows the identification of functional related clus-
ters, indicates that protein binding from molecular func-
tion (Figure 4A) and cellular physiological process from
biological process (Figure 4B) represent the largest pro-
portion (approximately 25%), respectively, in either cate-
gory. This analysis raises the possibility that these HCC-
related genes might not act alone randomly, but have a
propensity to associate physically or functionally to per-
turb the fundamental biological processes of the liver.
To uncover the potential interaction networks or synergis-
tic effects of these seemingly unrelated HCC-related genes,
we employed each up-regulated gene set as queries and
searched for their interaction partners by accessing our
previously established protein-protein interaction (PPI)
data [31,32]. Figure 4C summarizes the analysis results.
We used GIS dataset as the first example because all tissue
samples in the study were HBV-associated HCC patients.
GIS consists of 161 overexpressed genes, but 22 of them
have no PPI information. Of the remaining 139 queries,
45 of them (32.4%) could interact with each other (Figure
4C and 4D) and form 55 PPIs. Moreover, 28 queries serve
as "hubs" (Figure 4D label with red circle), which are
referred to as queries interact with more than one query in
a given PPI network (see later). Next, we used Lee_NIH as
the second example because this study was using mouse
model to recapitulate the HCC and may provide novel
insight toward the hepatocarcinogenesis. Similarly, of 149
queries with available PPI data, 52 of them (34.9%) can
interact with each other to constitute 43 PPIs and 29 hubs
can be revealed (Figure 4E label with red circle). Both que-
ries in the inferred networks belong to primarily cellular
physiological process and metabolism from biological
process in GO. Together, transformation of these seem-
ingly random genes into their corresponding PPI reveals
the intrinsic dys-regulated biological network in HCC and
highlights the potential new hubs for discovery of the
potential HCC markers or therapeutic targets.
Evaluation of "hubs" in the conserved HCC network at the 
systems level
It has been illustrated using the yeast PPI network that this
network is scale-free, in which some proteins have many
more interactions than others [33]. A survey of the yeast
protein interaction network has revealed that proteins
with more interactions are more important than those
with fewer interacting proteins [34], suggesting that hub
degree is an indicator for essentialness in a network. How-
ever, it is difficult to address the essentialness of these
newly identified hubs (or potential new targets for hepa-
tocarcinogenesis) from the inferred biological network as
described in Figure 4D and 4E. Therefore, we employed
the comparative genomics approach for the availability of
knockout phenotype from various model organisms. To
Table 1: Top 23 genes that appear most frequently in 6 mRNA-related gene sets in EHCO.
Count Symbol SMD1648 SAGE GIS LEE KIM TableX_mRNA
5 SCP2 Down Down Down Down Down
4 ADH1B Down Down Down Down
ALB Down Down Down Down
ARG1 Down Down Down Down
CAT Down Down Down Down
CP Down Down Down Down
CPB2 Down Down Down Down
CRHBP Down Down Down Down
CYP2C9 Down Down Down Down
CYP2E1 Down Down Down Down
FGB Down Down Down Down
GHR Down Down Down Down
HPD Down Down Down Down
HSD17B6 Down Down Down Down
MT1B Down Down Down Down
PCK1 Down Down Down Down
PHYH Down Down Down Down
TF Down Down Down Down
TTR Down Down Down Down
FABP1 Down Down Down Up
IGFBP3 Down Up Down Down
NNMT Down Down Down Up & Down
SGK Down Down Down UpBMC Bioinformatics 2007, 8:66 http://www.biomedcentral.com/1471-2105/8/66
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reduce the complexity, we focused on those genes only
conserved in evolution, which may represent, at least in
part, the dys-regulation of essential cellular physiological
roles in hepatocarcinogenesis as concluded in GO analy-
sis (Figure 4B). Based on the HomoloGene orthologues
database (build50.1), 228 genes, consisting of 139 up-
and 78 down-regulated genes, out of 2906 EHCO collec-
tions are conserved range from H. sapiens, M. musculus, C.
elegans, D. melanogaster, to S. cerevisiae (Figure 5A). Of 139
queries, 120 queries with PPI data were individually sub-
jected to search for their interaction partners. 47 out of
120 queries (~40%) were associated with each other and
there were 18 hubs (Figure 5B, labeled in red) in this net-
work. By using the available phenotypic information from
WormBase [44], FlyBase [45], and SGD [46], the percent-
age of nonviable phenotypes, e.g. embryonic or larval
lethality, or sterility, in these 18 hubs was higher than
those 120 queries (Figure 5C). Moreover, of these 18 hubs
with more interaction proteins, the ratio of nonviable
phenotype in yeast seemed to be higher than those with
fewer interaction proteins (Figure 5D). This analysis
seems to be able to shed light on which research can be
based to study potential new players in HCC research in
the post-genomic era through the systems biology
approach.
Conclusion
The collected genes or associated pathways in EHCO may
represent only small part of the whole genome or our
understanding of hepatocarcinogenesis. This network
construction supporting the view that well coordinated
interaction networks may be required for these aberrant
HCC-related genes to modulate hepatocarcinogenesis.
Targeting multiple hubs and/or disruption of the network
formation could offer an excellent opportunity to reveal
potential strategy for HCC treatment.
Methods
Text-mining to acquire HCC-related gene sets
The fundamental part of EHCO is the collections of eight
gene sets related to HCC. The text-mining method to
acquire HCC-related literatures from PubMed used "hepa-
tocellular carcinoma" as a keyword. This study used the
latest approved human genome nomenclature from
HUGO Gene Nomenclature Committee [47]. A simple
text-matching program was written to look for the pres-
Validation the EHCO dataset by quantitative RT-PCR Figure 3
Validation the EHCO dataset by quantitative RT-PCR. (A) NNMT is down-regulated and (B) PEG10 is overexpressed 
in HCC. The mRNA expression levels of NNMT and PEG10 were determined by quantitative RT-PCR in 21-pairwised HCC 
patients. Results were normalized against the mRNA expression level of ACTB (A) and GAPDH (B) in each sample.
(A)                 (B) BMC Bioinformatics 2007, 8:66 http://www.biomedcentral.com/1471-2105/8/66
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Detection of inferred biological network of HCC Figure 4
Detection of inferred biological network of HCC. (A, B) Gene Ontology (GO) analysis reveals top 5 categories in 
molecular function and biological process. Protein binding is the largest proportion in molecular function (A), whereas cellular 
physiological process ranks number one in the biological process (B). (C, D, E) Detection of protein-protein interaction (PPI) 
network from various gene sets. Only up-regulated genes (referred to as queries) in each gene set are subjected to search for 
their interaction partners. Many queries can form interaction network among query themselves, despite the fact that many 
queries do not have PPI data. (D) Of 139 GIS queries, 45 of them can form 55 PPI to constitute the interaction networks and 
28 (red circle) of them serve as hubs (referred to as interacting with more than one query, including homo-dimer). (E) Of 149 
Lee_NIH queries with available PPI data, 52 of them (34.9%) can interact with each other and form 62 PPIs.
(A)              (B) 
( C )            
(D)                (E)BMC Bioinformatics 2007, 8:66 http://www.biomedcentral.com/1471-2105/8/66
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ence of HUGO-approved gene names, symbols, and ali-
ases, in the title and abstract part of HCC-related
literatures, resulting in acquiring approximately 24,300
abstracts. Because one publication may contain several
genes, we curated the results by removing redundancy and
obtained 10,425 abstracts. These potential HCC-related
abstracts and gene lists were further verified to remove
unrelated abstracts by natural language processing, fol-
lowed by manual read through by biology major graduate
students, research associates and postdoctoral fellows.
Finally, in the PubMed category, we had extracted 1,084
genes from 4,492 abstracts.
Information retrieval and extraction by natural language 
processing
To elucidate the relationship between the EHCO collected
genes and HCC, we applied a natural language processing
(NLP) technique to extract information from the litera-
ture. We performed biological information retrieval
(BioIR) to obtain PubMed abstracts that may contain
An architectural map of the conserved HCC network at the systems level Figure 5
An architectural map of the conserved HCC network at the systems level. (A) 228 HCC-related genes in EHCO 
collections are evolution conserved cross various species. EHCO collects 2906 HCC-related H. sapiens genes, of which 2,635 
genes have M. musculus homologs (point by arrow) and 114 genes cannot find any homologs (point by node). Of 2635 M. mus-
culus genes, there are 774 genes with C. elegans homologs and 324 genes have D. melanogaster homologs, but do not have C. ele-
gans homologs (branch and point by arrow). In short, 228 genes are conserved from H. sapiens to S. cerevisiae. (B) Conserved 
HCC network. Among 139 overexpressed and evolutionary conserved HCC-related genes, 120 of them have at least one PPI 
record. 47 of them can interact with each other and constitute a network and 18 of them are query-also-hubs (red circle). (C) 
Evaluation of the essentialness of hubs. To evaluate the essentialness of hubs, 139 queries, 47 queries constituting of interaction 
network, and 18 query-also-hubs were subjected to search for the nonviable phenotype in their corresponding homologs in 
various model organisms, including C. elegans, D. melanogaster, and S. cerevisiae. (D) Evaluation of the feature of hub degree. The 
degree, which is referred to as number of interactions associated with a protein, is considered to be one of the features in 
determining the essentialness of hubs. 18 query-also-hubs, which have various degrees ranging from 2–7, were subjected to 
search for the nonviable phenotype in their corresponding homologs in S. cerevisiae. The relative ratio is shown.
(A)                (B) 
(C)                (D) 
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gene-HCC relationships, followed by information extrac-
tion to reveal gene-HCC relationships. BioIR started with
searching for keyword combinations, i.e. (gene symbol or
aliases) and (hepatocellular carcinoma). 10,425 PubMed
abstracts were scanned to search for HCC candidate genes.
We filtered out abstracts irrelevant to gene-HCC relation-
ships by eliminating those abstracts that HCC and genes
did not co-occur in the same sentence since most NLP
techniques only handled information in the same line.
5,942 abstracts were found to contain gene-HCC relation-
ships. Biology majored associates were manually read
through the abstracts, resulting in the validation of 4,492
abstracts. The accuracy (or precision in NLP terminology)
is about 75%. Error analysis on the output and retrieved
abstracts indicates that most of errors were caused by lack
of sufficient syntactic patterns. The retrieved relevant
PubMed abstracts were then subjected to automated
information extraction.
To extract information related to a certain topic, the
extraction tool needs to be capable of accomplishing two
tasks: (1) Named Entity Recognition (NER): to recognize
biomedical named entities (NEs) (e.g. afp, alb, mRNA
and HCC); and (2) Named Entity Relation Recognition
(NERR): to recognize relationships of interest between
NEs (e.g. HCC and mRNA level). NER in biomedical
domain is a challenging problem in natural language
processing for the following reasons. Most biomedical
named entities have no nomenclature. They may include
long compound words (e.g. hepatocellular carcinoma), or
unknown words that include hyphen, digit, Greek letter,
or Roman numeral (e.g. 4'-mycarosyl isovaleryl-CoA
transferase). Abbreviations and acronyms may also
appear as unknown words and frequently cause ambigu-
ity in their meanings. Moreover, named entities may
involve variations in spelling (e.g. N-acetylcysteine, N-
acetyl-cysteine, NacetylCysteine) or in expressions (e.g.
EGF receptor and EGFR). To handle this NER problem, we
constructed a NE dictionary that contains the following
NEs and NE classes along with their aliases: gene, protein,
mRNA, serum, hepatitis B virus (HBV), hepatitis C virus
(HCV), methylation, liver regeneration, HCC, cirrhosis,
fibrosis, and necrosis. We used dictionary-based method,
i.e. a dictionary and a fast matching algorithm, to identify
NEs of our interest occurring in the PudMed abstracts.
Next, we proceeded to investigate the relationship
between NEs by using a natural language parser to assign
part-of-speech annotation, and co-occurrences of terms,
and template-based methods. The overall automated pro-
cedure to extract gene-HCC relationships for our gene-
HCC knowledge base system is shown in Figure 1B.
Patients and tumor samples
21 pairs of tumor and adjacent non-tumor liver tissues
were collected from 1996 to 2000 at the Division of Gen-
eral Surgery of Kaohsiung Veterans General Hospital
(VGH). No patients had previously received any treat-
ment, e.g. chemotherapy, for HCC. The study protocol
had the approval of the ethics committee at Kaohsiung-
VGH. All patients gave informed consents. Study samples,
including tumor and adjacent non-tumor liver tissues,
were obtained during diagnostic biopsy, and non-tumor
liver tissues were derived from neighboring site outside of
the tumor. Both tumor and adjacent non-tumor liver tis-
sues for subsequent studies were confirmed by patholo-
gists and were used for quantitative RT-PCR (or Q-RT-
PCR). The detailed protocols for RNA isolation and SYBR
Green I based quantitative RT-PCR were as described pre-
viously [35].
Availability and requirements
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